Literature DB >> 29446288

Adjuvant Therapy in Resected Melanoma.

Jeffrey Weber1, Anila Qureshi2, Paolo A Ascierto3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29446288     DOI: 10.1056/NEJMc1716071

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts.

Authors:  Claus Garbe; Ulrike Keim; Stefan Suciu; Teresa Amaral; Thomas K Eigentler; Anja Gesierich; Axel Hauschild; Lucie Heinzerling; Felix Kiecker; Dirk Schadendorf; Rudolf Stadler; Cord Sunderkötter; Thomas Tüting; Jochen Utikal; Uwe Wollina; Christos C Zouboulis; Ulrich Keilholz; Alessandro Testori; Peter Martus; Ulrike Leiter; Alexander M M Eggermont
Journal:  J Clin Oncol       Date:  2020-06-12       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.